12:00 AM
Mar 13, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Rotarix: Began Phase I/II studies

SmithKline Beecham (LSE:SB; SBH), Philadelphia, Penn.
Product: Rotarix
Business: Infectious diseases
Therapeutic category: Viral infection, Immune...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >